Chronic obstructive pulmonary disease

Insights on the Digital Therapeutics Global Market to 2027 - by Application, End-use and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, July 8, 2022
Managed Care, Health Technology, Health, Degenerative disease, ADHD, Schizophrenia, Patient, Single-frequency network, Autism, Attention deficit hyperactivity disorder, COVID-19, Growth, Roy Taylor (scientist), Depression, Prevalence, Obesity, Digital, Therapy, Lists of diseases, ASD, Tablet, Alzheimer's disease, Health, Asthma, Chronic obstructive pulmonary disease, Pharmaceutical industry, Medical device

What has been the impact of COVID-19 on the global digital therapeutics market?

Key Points: 
  • What has been the impact of COVID-19 on the global digital therapeutics market?
  • What is the breakup of the global digital therapeutics market based on the end use?
  • What are the key regions in the global digital therapeutics market?
  • 8. Who are the key players/companies in the global digital therapeutics market?

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is Predicted to Expand at a CAGR of 4.4% during the Forecast Period, notes TMR Study

Retrieved on: 
Thursday, July 7, 2022
Diagnosis, Irritant, Ageing, Patient, Global Initiative, Lists of countries and territories, Projection, COPD, Weather, Pollen, GOLD, Urinary tract infection, Population, Atmosphere, US, Profile, Prevalence, Awareness, CAGR, Dust, MITES, Risk, Incidence, Pharmacy, Ragweed, Allergen, Risk factor, Chronic obstructive pulmonary disease, Smoke, Pharmaceutical industry, Poultry, Health insurance

The global market is anticipated to rise at a CAGR of 4.4% during the forecast period, from 2022 to 2031.

Key Points: 
  • The global market is anticipated to rise at a CAGR of 4.4% during the forecast period, from 2022 to 2031.
  • As such, the market for chronic obstructive pulmonary disease treatment is expected to increase in the near future.
  • Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Growth Drivers
    The global chronic obstructive pulmonary disease treatment market is anticipated to grow due to an increase in the number of patients who are effectively treated with combination therapy but did not improve with corticosteroid orbronchodilators therapies.
  • Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Key Players

Make Caring for a Loved One with COPD Easier

Retrieved on: 
Tuesday, July 5, 2022
National Heart Valve Disease Awareness Day, National Heart, Lung, and Blood Institute, Caregiver, Respiratory Health Association, Microsoft family features, Lung, COPD, Chronic obstructive pulmonary disease, Residential care

MISSION, Kan., July 5, 2022 /PRNewswire/ -- (Family Features) Many people care for someone with a long-term health condition, like chronic obstructive pulmonary disease (COPD).

Key Points: 
  • MISSION, Kan., July 5, 2022 /PRNewswire/ -- (Family Features) Many people care for someone with a long-term health condition, like chronic obstructive pulmonary disease (COPD).
  • Being a caregiver can be stressful, and if you care for someone with COPD, you may have to juggle many roles.
  • Caregivers need to take care of themselves, too.
  • The National Heart, Lung, and Blood Institute's Learn More Breathe Better program and Respiratory Health Association have joined forces to launch The COPD Caregiver's Toolkit to help simplify the hardest parts of being a caregiver.

Worldwide Respiratory Protective Equipment Industry to 2027 - Featuring 3M, Alpha Pro Tech and Honeywell International Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, July 4, 2022
Medical Devices, Health, MSA Safety, Mesothelioma, Honeywell, ADF, Nose, COPD, Research, R, Personal protective equipment, ILC Dover, Mask, COVID-19, Growth, Industry, Gas, LP, PPE, Atmosphere, Mouth, Health, Mining, Lung cancer, Face, Textile, Awareness, Plant, 3M, Occupational asthma, RPE, Dangerous, Government, Chronic obstructive pulmonary disease, Potash, Pneumoconiosis

The respiratory protective equipment (RPE) refers to a kind of personal protective equipment (PPE) that safeguards the wearer from inhaling hazardous substances, dust particles and gases in the air.

Key Points: 
  • The respiratory protective equipment (RPE) refers to a kind of personal protective equipment (PPE) that safeguards the wearer from inhaling hazardous substances, dust particles and gases in the air.
  • These equipment are commonly used in chemicals, textiles and paper processing mills, along with metalworking plants and construction sites.
  • The competitive landscape of the industry has also been examined with some of the key players being 3M Company, Alpha Pro Tech Limited, E.D.
  • What is the structure of the global respiratory protective equipment market and who are the key players?

Air Purification Equipment Global Market Report 2022

Retrieved on: 
Friday, July 1, 2022
Air conditioning, Geography, Acquisition, Death, Quanta Computer, Inc. v. LG Electronics, Inc., Carbon, Technology, Ion, COVID-19, Growth, Stroke, Industry, Forecasting, Atmosphere, Lung cancer, Air pollution, World, 3M, Risk, Atmosphere of Earth, Partnership, Environment, HVAC, Dust, Panasonic, Organization, World Health Organization, Degenerative disease, Ozone, Daikin, Maintenance, Sharp Corporation, Demography, Chronic obstructive pulmonary disease, Honeywell, HEPA, WHO, Fine chemical, Retail, Oil, Heating, ventilation, and air conditioning, Fossil fuel, Lithium

DUBLIN, July 1, 2022 /PRNewswire/ --The "Air Purification Equipment Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 1, 2022 /PRNewswire/ --The "Air Purification Equipment Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • It compares the air purification equipment market with other segments of the air purification equipment market by size and growth, historic and forecast
    Major players in the air purification equipment market are Daikin Industries Ltd, Sharp Corporation, Camfil Group, Philips Electronics N.V, LG Electronics Inc, Panasonic Corporation, 3M Company, Mann+Hummel, Honeywell International Inc, and Clarcor Inc.
  • The air purification equipment market consists of sales of air purification equipment by entities (organizations, sole traders, and partnerships) that produce air purification equipment that is used for removing contaminants from the air in a room to improve indoor air quality.
  • The main product types of air purification are stand-alone air purification equipment and induct air purification equipment.

Global Air Purification Equipment Market to 2031 - Featuring Daikin Industries, Sharp, Camfil and Philips Electronics Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 30, 2022
Health, Other Construction & Property, Residential Building & Real Estate, COVID-19, Commercial Building & Real Estate, Construction & Property, Death, Carbon, Ion, Growth, Stroke, Industry, Atmosphere, Lung cancer, Air pollution, World, Risk, Partnership, Environment, HVAC, Dust, World Health Organization, Organization, Ozone, Degenerative disease, Maintenance, Chronic obstructive pulmonary disease, HEPA, WHO, Heating, ventilation, and air conditioning, Fossil fuel

The air purification equipment market consists of sales of air purification equipment by entities (organizations, sole traders, and partnerships) that produce air purification equipment that is used for removing contaminants from the air in a room to improve indoor air quality.

Key Points: 
  • The air purification equipment market consists of sales of air purification equipment by entities (organizations, sole traders, and partnerships) that produce air purification equipment that is used for removing contaminants from the air in a room to improve indoor air quality.
  • The main product types of air purification are stand-alone air purification equipment and induct air purification equipment.
  • The risk and high maintenance charges associated with the air purification equipment are expected to limit the growth of the air purification equipment market.
  • These disadvantages associated with the usage of air purification systems are expected to hamper the air purification equipment market during the forecasted period.

Global Respiratory Monitoring Devices Markets Report 2022: Capnographs, Gas Analyzers, Pulse Oximeters, Peak Flow Meters, Spirometers, Polysomnographs - Long-term Forecasts to 2026 & 2031 - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 30, 2022
Medical Devices, Health, Medication, FDA, GE Healthcare, Chronic Respiratory Disease, COPD, Carbon, Traversa, Laboratory, COVID-19, Covidien, Growth, ResMed, Health care, Quark Pharmaceuticals, Polysomnography, Infection, Bronchitis, Pneumonia, Siemens Healthineers, Philips, Degenerative disease, CO-oximeter, Time, Merck & Co., Asthma, Chronic obstructive pulmonary disease, Therapy, Hospital, Medical device, Poultry, Dietary supplement

The respiratory monitoring devices market consists of sales of respiratory monitoring devices used to monitor respiration-related parameters that aid the detection of acute or chronic respiratory disorders.

Key Points: 
  • The respiratory monitoring devices market consists of sales of respiratory monitoring devices used to monitor respiration-related parameters that aid the detection of acute or chronic respiratory disorders.
  • The main types of respiratory monitoring devices are capnographs, gas analyzers, pulse oximeters, peak flow meters, spirometers, polysomnography, and others.
  • The rising rate of chronic respiratory diseases is expected to drive the respiratory monitoring devices market in near future.
  • The longer duration of time taken in the approval process of respiratory devices is restricting the growth of the respiratory monitoring devices market.

Invacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference

Retrieved on: 
Tuesday, June 28, 2022
General Health, Finance, Medical Devices, Health, Professional Services, Invacare, Rest, COPD, Multiple sclerosis, Stroke, ALS, Cerebral palsy, Treasury, NYSE, Muscular dystrophy, Spina bifida, IVC, Government, Health, Chronic obstructive pulmonary disease, Rancho Los Amigos National Rehabilitation Center, Conference, Health insurance

Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations and corporate communications, will participate in the 22nd Annual New Ideas Summer Conference on Tuesday, July 12, 2022.

Key Points: 
  • Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations and corporate communications, will participate in the 22nd Annual New Ideas Summer Conference on Tuesday, July 12, 2022.
  • The companys management team will be available for 1x1 meetings with interested investors.
  • Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings.
  • At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene.

CMS Assigns New Technology Payment Classification for Optellum's Lung Cancer Prediction Score

Retrieved on: 
Tuesday, June 28, 2022
Diagnosis, Patient, One Oxford Centre, National Institute, Health, SEER, LCP, Interstitial lung disease, AAC, Degenerative disease, Department, FDA, Centers for Medicare & Medicaid Services, Lung cancer, Texas Medical Center, Radiology, MD Anderson Cancer Center, CT, Medical University of South Carolina, Investment, Academic health science centre, BS, Medical school, NLST, National Lung Screening Trial, Twitter, III, LinkedIn, ILD, COPD, Center, National Institute for Health Research, NIHR, NHS, Certification, Technology, Survival rate, AI, Multimedia, Hospital, MedCity, CMS, Disease, Professor, CE, CPT, UKCA, Medicine, Physician, Chronic obstructive pulmonary disease, Medical imaging, Medical device, Epidemiology, Medicare

HOUSTON and OXFORD, United Kingdom, June 28, 2022  /PRNewswire/ -- Optellum announced that the Centers for Medicare & Medicaid Services (CMS) has established a national payment rate for Optellum's Lung Cancer Prediction technology under the New Technology Ambulatory Payment Classification. This development will facilitate the process of health insurance claims for individuals enrolled in Medicare and other health insurance programs, enabling more patients to access innovative, potentially life-saving early lung cancer diagnostic technology.

Key Points: 
  • HOUSTON and OXFORD, United Kingdom, June 28, 2022 /PRNewswire/ -- Optellum announced that the Centers for Medicare & Medicaid Services (CMS) has established a national payment rate for Optellum's Lung Cancer Prediction technology under the New Technology Ambulatory Payment Classification.
  • "This is another step in Optellum's progress towards becoming the standard of care for early lung cancer diagnosis.
  • "This new payment assignment is an important step towards incentivizing providers to make the technology more widely available."
  • He has extensive experience in the application and translation of imaging research for evaluating lung nodules and lung cancer.

Emphysema Epidemiology and Market Report 2022: Seven Major Market Analysis - ResearchAndMarkets.com

Retrieved on: 
Friday, June 24, 2022
Health, Other Health, Organizing, Diagnosis, Awareness, United Kingdom, Disease, Research, Pharmaceutical industry, Chronic obstructive pulmonary disease

In the coming years, Emphysema market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market

Key Points: 
  • In the coming years, Emphysema market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
    The companies and academics are working to assess challenges and seek opportunities that could influence Emphysema R&D.
  • The therapies under development are focused on novel approaches to treat/improve the disease condition
    Major players are involved in developing therapies for Emphysema.
  • Launch of emerging therapies will significantly impact the Emphysema market
    Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities
    The report covers the descriptive overview of Emphysema, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
    Additionally, an all-inclusive account of both the current and emerging therapies for Emphysema are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
    A detailed review of Emphysema market; historical and forecasted is included in the report, covering drug outreach in the 7MM
    The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Emphysema market
    Organize sales and marketing efforts by identifying the best opportunities for Emphysema in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan